Results of a nation-wide cohort study suggest favorable long-term outcomes of clone-targeted chemotherapy in immunotactoid glomerulopathy
Vincent Javaugue(Université de Poitiers), Frank Bridoux(Université de Poitiers), Jean‐Paul Fermand(Sorbonne Université), Lionel Karlin(Hôpital Lyon Sud), Viviane Gnemmi(Université Paris-Saclay), Guy Touchard(Centre Hospitalier Universitaire de Poitiers), Pascal Bindi, Cyril Garrouste(Centre Hospitalier Universitaire de Clermont-Ferrand), Éstelle Desport(Centre Hospitalier Universitaire de Poitiers), Audrey Sibille(Université de Poitiers), Léa Dufour-Nourigat(Université de Poitiers), M. Nouvier(Hôpital Lyon Sud), Jean‐Michel Goujon(Centre Hospitalier Universitaire de Poitiers), Bruno Moulin(Université de Strasbourg), Christophe Mariat(Centre Hospitalier Universitaire de Saint-Étienne), Pierre Bataille
Cited by 44
Related Papers
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
|European Heart Journal|2012|6.9k
ESC/EAS Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)
|European Heart Journal|2011|3.5k
KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases
|Kidney International|2021|2.5k
Teclistamab in Relapsed or Refractory Multiple Myeloma
|New England Journal of Medicine|2022|1.2k
Executive summary of the KDIGO 2021 Guideline for the Management of Glomerular Diseases
|Kidney International|2021|809